Prelude Therapeutics (PRLD) Q4 2025 Earnings

Nov 12Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.47
-0.4
-0.33
-0.26

Details

Expected EPS
-0.37
Actual EPS
-0.26
Surprise EPS
0.11
Surprise Percent
+29.73%

Description

⁨Prelude Therapeutics⁩ (⁦PRLD⁩) has reported earnings of ⁦-0.26⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts